跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 40,146 条关于
“unresectable liver tumors”
全部
40,146
临床试验
30,996
药物
934
机构
102
资讯
8,114
7个月前
University of Missouri Launches First On-Campus Radiopharmaceutical Clinical Trial Using Eye90 Microspheres for Liver Cancer
4个月前
HistoSonics' Edison Histotripsy System Earns Taiwan FDA Approval for Non-Invasive Liver Tumor Treatment
去年
Sirtex Medical's SIR-Spheres Y-90 Resin Microspheres Receive FDA Approval for Unresectable Hepatocellular Carcinoma
去年
TACE Plus Camrelizumab and Rivoceranib Improves PFS in Unresectable HCC
3年前
FDA Approves AstraZeneca's Dual Immunotherapy Combination for Unresectable Liver Cancer
去年
CAIRO5 Trial: FOLFOX/FOLFIRI Plus Bevacizumab Shows Efficacy in Unresectable Colorectal Liver Metastases
去年
FDA Issues Second Rejection for Rivoceranib/Camrelizumab Combination in Unresectable Liver Cancer
2年前
Imfinzi and Imjudo Combo Shows Unprecedented 5-Year Survival in Liver Cancer
去年
Tecentriq and Avastin Combined with TACE Shows Significant Benefit in Unresectable Liver Cancer Trial
去年
Neoadjuvant Immunotherapy Shows Promise in Improving Outcomes for Liver Cancer Patients
第 1 页,共 812 页
上一页
下一页